Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the Infusion of RP-L102
Clinical trial NCT07527975 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07527975
- Sponsor
- Rocket Pharmaceuticals Inc.
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2022-02-01
- Primary completion
- 2038-05-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.